当药明康德的员工抱着纸箱走出研发园区时,纸箱里装载的不仅是私人物品,更折射出 CRO 行业十年狂飙后的转型阵痛。这家行业巨头 2024 年上半年交出上市以来最黯淡的成绩单:营收 172.41 亿元,同比下滑 8.64%;净利润 42.4 亿元,降幅达 20.2%。更触目惊心的是人员规模的收缩 —— 从 2022 年的 4.4 万峰值锐减近 5000 人,如今以 3.94 万员工数虽仍居行业榜首,却...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.